MTA1 and neoplasm: The CRL4B/NuRD(MTA1) complex could also promote cell response to the EMT and CSC‐related pathways, such as hypoxia, Wnt, and Notch, thereby promoting tumor metastasis as well as acquisition and maintenance of stem cell‐like properties.